Patent · US Active

N-substituted indenoisoquinolines and syntheses thereof

US9388211B2 · kind B2 · utility

3Cited by

2References

19Claims

0Family size

Assignees

Purdue Research Foundation · US
NATIONAL INSTITUTES OF HEALTH (NIH) · US

Inventors

Mark S. Cushman · West Lafayette, US
Andrew E. Morrell · San Diego, US
Muthukaman Nagarajan · Hyderabad, IN
Yves G. Pommier · Bethesda, US
Smitha Antony · Silver Spring, US
Keli K. Agama · Bowie, US
Daniel Edward Beck · West Palm Beach, US

Key dates

Filing date	Apr 15, 2015
Grant date	Jul 12, 2016
Priority date	—
Expiry date	Apr 15, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07J73/003
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

N-Substituted indenoisoquinoline compounds, and pharmaceutical formulations of N-substituted indenoisoquinoline compounds are described. Also described are processes for preparing N-substituted indenoisoquinoline compounds. Also described are methods for treating cancer in mammals using the described N-substituted indenoisoquinoline compounds or pharmaceutical formulations thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.